Optimization of gefitinib analogues with potent anticancer activity

Kai Hao Yin, Yi Han Hsieh, Rohidas S. Sulake, Su Pei Wang, Jui-I Chao*, Chinpiao Chen

*Corresponding author for this work

研究成果: Article同行評審

17 引文 斯高帕斯(Scopus)

摘要

The interactions of gefitinib (Iressa) in EGFR are hydrogen bonding and van der Waals forces through quinazoline and aniline rings. However the morpholino group of gefitinib is poorly ordered due to its weak electron density. A series of novel piperazino analogues of gefitinib where morpholino group substituted with various piperazino groups were designed and synthesized. Most of them indicated significant anti-cancer activities against human cancer cell lines. In particular, compounds 52-54 showed excellent potency against cancer cells. Convergent synthetic approach has been developed for the synthesis of gefitinib intermediate which can lead to gefitinib as well as numerous analogues.

原文English
頁(從 - 到)5247-5250
頁數4
期刊Bioorganic and Medicinal Chemistry Letters
24
發行號22
DOIs
出版狀態Published - 15 十一月 2014

指紋 深入研究「Optimization of gefitinib analogues with potent anticancer activity」主題。共同形成了獨特的指紋。

引用此